Reports

A key driver is the growing demand for non-invasive diagnostics.

Asia Pacific is projected to be the fastest-growing region.

It is driven by the increasing demand in pharmaceutical and biotechnology research.

There are 9,000 new cases of MCC in these markets.

It is driven by rising cases of coronary artery disease.

The steps can unleash further innovation in APAC and Japan's healthcare industries.

The last of four parts explores the future of UAE's healthcare in a post-pandemic world.

The third of four parts tackles how UAE continues to bounce back from setbacks brought by the pandemic.

In the first of four parts, the UAE's resilience intra- and post-pandemic were discussed.